IP Verse

Treating Pathological Conditions By Direct And Indirect Targeting Of Sirpa - Cd47 Interaction

Patent No. EP3658141 (titled "Treating Pathological Conditions By Direct And Indirect Targeting Of Sirpa - Cd47 Interaction") was filed by Academisch Ziekenhuis Leiden Hodn Lumc on Jul 24, 2018. The application was issued on Nov 16, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANAug 11, 2023HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3658141

ACADEMISCH ZIEKENHUIS LEIDEN HODN LUMC
Application Number
EP18770099A
Filing Date
Jul 24, 2018
Status
Granted And Under Opposition
Oct 14, 2022
Publication Date
Nov 16, 2022
External Links
Slate, Register , Google Patents